"The Effect of Inhaled Nitroglycerin for COPD Patients
Recruiting · NCT06785337 · Interventional (participants receive a specific treatment) · Lead sponsor: Beni-Suef University
View the official record on ClinicalTrials.gov →Interventions studied
Inhaled nitroglycerin
What this trial is about
this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2, Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult patient's ≥ 18 years old COPD exacerbation with respiratory failure and Echo evidenced presence of pulmonary hypertension (defined as mean pulmonary artery pressure \> 20 mmHg)
Exclusion criteria
- Profound left ventricular failure, as the decrease in pulmonary vascular resistance results in an increase in left ventricular preload. This may worsen cardiogenic pulmonary edema.
- Pregnant female patients
- Patient with hypersensitivity to nitroglycerin
Where it is running
1 location listed.
- Haram Hospital - Haram, Giza Governorate, Egypt